The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis
Open accessAbstract
The antifungal activity of caspofungin acetate (CAS) alone and in combination with voriconazole (VRC) was evaluated in an immunosuppressed transiently neutropenic guinea pig model of invasive aspergillosis. Guinea pigs were immunosuppressed with triamcinolone at 20 mg/kg of body weight/day subcutaneously beginning 4 days prior to lethal intravenous challenge with Aspergillus fumigatus and were made temporarily neutropenic with cyclophosphamide administered at 150 mg/kg intraperitoneally (i.p.) 1 day prior to challenge. Therapy with i.p. CAS at 1 and 2.5 mg/kg/day (with and without oral VRC at 5 mg/kg/day), oral VRC at 5 mg/kg/day, or i.p. amphotericin B (AMB) at 1.25 mg/kg/day was begun 24 h after challenge and was continued for 5 days. Mortality occurred in 12 of 12 untreated controls, whereas mortality occurred in 4 of 12 and 6 of 12 guinea pigs treated with CAS at 1 and 2.5 mg/kg/day, respectively, and in 3 of 12 guinea pigs treated with AMB. No mortality occurred among animals treated with CAS at 1 mg/kg/day plus VRC at 5 mg/kg/day, CAS at 2.5 mg/kg/day plus VRC at 5 mg/kg/day, or VRC at 5 mg/kg/day alone. Both CAS regimens increased the survival times and reduced the colony counts in tissue compared with those for the controls. Treatment with VRC and AMB significantly reduced the colony counts in the tissues of selected animals compared with those in the tissues of the controls. Treatment with VRC and AMB also resulted in reductions in colony counts in tissues compared with those in the tissues of animals treated with CAS (the difference was not statistically significant) and improved the survival times but did not sterilize tissues. Combination therapies with CAS plus VRC at either dose reduced colony counts in tissues 1,000-fold over those for the controls and were the only regimens that significantly reduced the numbers of positive cultures. The combinations of CAS plus VRC were highly effective in this model and should be further evaluated for use against invasive aspergillosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Aspergillus fumigatus and Aspergillosis
Latgé, J.-P. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.310 · Cited by 2,307
Denning, D. W. (1998) · Clinical Infectious Diseases · doi:10.1086/513943 · Cited by 1,492
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791
Self-citationEspinel-Ingroff, A. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.10.2950-2956.1998 · Cited by 576
In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872)
Bartizal, K., Gill, C. J., Abruzzo, G. K., Flattery, A. M., Kong, L., Scott, P. M., Smith, J. G., Leighton, C. E., Bouffard, A., Dropinski, J. F., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2326 · Cited by 311
Abruzzo, G. K., Flattery, A. M., Gill, C. J., Kong, L., Smith, J. G., Pikounis, V. B., Balkovec, J. M., Bouffard, A. F., Dropinski, J. F., Rosen, H., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.11.2333 · Cited by 241
Bowman, J. C., Abruzzo, G. K., Anderson, J. W., Flattery, A. M., Gill, C. J., Pikounis, V. B., Schmatz, D. M., Liberator, P. A., & Douglas, C. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3474-3481.2001 · Cited by 208
In Vitro Susceptibility Testing Methods for Caspofungin against Aspergillus and Fusarium Isolates
Arikan, S., Lozano-Chiu, M., Paetznick, V., & Rex, J. H. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.327-330.2001 · Cited by 202
Abruzzo, G. K., Gill, C. J., Flattery, A. M., Kong, L., Leighton, C., Smith, J. G., Pikounis, V. B., Bartizal, K., & Rosen, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2310-2318.2000 · Cited by 171
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species
Ryder, N. S., & Leitner, I. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.91.95 · Cited by 129
Barry, A. L., & Brown, S. D. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1948 · Cited by 123
Martin, M. V., Yates, J. O., & Hitchcock, C. A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.1.13 · Cited by 110
Patterson, T. F., Miniter, P., Dijkstra, J., Szoka, F. C., Ryan, J. L., & Andriole, V. T. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.4.717 · Cited by 93
Self-citationActivity of terbinafine against serious fungal pathogens
Ryder, N. S. (1999) · Mycoses · doi:10.1111/j.1439-0507.1999.tb00026.x · Cited by 91
Roberts, J. C., Schock, K. D., Marino, S., & Andriole, V. T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3381-3388.2000 · Cited by 89
Efficacy of Voriconazole in a Guinea Pig Model of Disseminated Invasive Aspergillosis
Kirkpatrick, W. R., McAtee, R. K., Fothergill, A. W., Rinaldi, M. G., & Patterson, T. F. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.10.2865-2868.2000 · Cited by 83
Self-citationSanati, H., Ramos, C. F., Bayer, A. S., & Ghannoum, M. A. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1345 · Cited by 76
Barchiesi, F., Francesco, L. F. D., Compagnucci, P., Arzeni, D., Giacometti, A., & Scalise, G. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.1.59 · Cited by 69
Compartmental Pharmacokinetics of the Antifungal Echinocandin Caspofungin (MK-0991) in Rabbits
Groll, A. H., Gullick, B. M., Petraitienė, R., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.596-600.2001 · Cited by 58
Combination Therapy in Experimental Invasive Aspergillosis
George, D., Kordick, D. L., Miniter, P., Patterson, T. F., & Andriole, V. T. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.3.692 · Cited by 51
Self-citationGraybill, J. R., & Kaster, S. R. (1984) · PubMed · Cited by 47
Chiller, T. M., Farrokhshad, K., Brummer, E., & Stevens, D. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3302-3305.2000 · Cited by 39
Lozano‐Chiu, M., Arıkan, S., Paetznick, V. L., Anaissie, E. J., & Rex, J. H. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.9.2755-2759.1999 · Cited by 38
Odds, F. C., Oris, M., van Dorsselaer, P., & Gerven, F. V. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3180-3183.2000 · Cited by 37
Efficacy of itraconazole solution in a rabbit model of invasive aspergillosis
Patterson, T. F., Fothergill, A. W., & Rinaldi, M. G. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.11.2307 · Cited by 35
Self-citationPatterson, T. F., George, D., Miniter, P., et al. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.3.575 · Cited by 26
Self-citationEfficacy of SCH 39304 in treatment of experimental invasive aspergillosis
Patterson, T. F., George, D., Ingersoll, R., Miniter, P., & Andriole, V. T. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.10.1985 · Cited by 22
Self-citation
Cited by
Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926
Self-citationWalsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,706
Self-citationTackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131
Combination Antifungal Therapy for Invasive Aspergillosis
Marr, K. A., Boeckh, M., Carter, R. A., Kim, H. W., & Corey, L. (2004) · Clinical Infectious Diseases · doi:10.1086/423380 · Cited by 596
Metadata
- Authors
- Kirkpatrick, W. R., Perea, S., Coco, B. J., & Patterson, T. F.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2002-08
- Volume
- 46
- Issue
- 8
- Pages
- 2564-2568
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2129942501
- Cited by
- 282
- References
- 28
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.